Atlas Trials

A Phase 1 Study of KHN702 Tablets in Healthy Subjects

Clinical trial NCT07044960 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07044960
Sponsor
Chengdu Kanghong Pharmaceutical Group Co., Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2025-06-21
Primary completion
2026-04-01
Enrollment
84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.